Girihlet

Non-canonical genomics

Oakland, United States · Founded 2012 · $250K raised

Employees
1–10
Founded
2012
Business Model
B2B
Total Funding
$250K
Last Round
$250K SeedOct 2015
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 2 investors for this company. The full record is or through the API.

About

Girihlet is a genomics company based in Oakland, California focused on non-canonical genomics with an emphasis on mitochondrial DNA analysis and immune repertoire sequencing. The company develops tools for T cell receptor (TCR) repertoire profiling and immune monitoring. Founded in 2012, Girihlet also maintains operations in Brooklyn, New York.

Summary

Girihlet is a Biotech company based in Oakland, United States, founded in 2012. It has raised $250K in total across 1 round, most recently a $250K Seed round in Oct 2015. Investors include IndieBio and Digitalis Ventures.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

SeedSeed RoundOct 2015
$250K

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Girihlet on Indexed.vc
<a href="https://indexed.vc/companies/girihlet"><img src="https://indexed.vc/api/badge/company/girihlet" alt="Girihlet on Indexed.vc" width="260" height="76" /></a>